In this study, we found that SLC and costunolide inhibit TNFα-mediated breast cancer cell migration and invasion by inhibiting NF-κB activation, thereby suggesting the antimetastatic property of costunolide using highly metastatic MDA-MB-231 breast cancer cells. Here, NFKB1 is linked to breast cancer.